StockData
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB) income statement

CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.80−0.09 (-9.73%)

Close on Nov 20, 2026Market cap $7.53MP/E –Yield –

See a number that looks wrong?